XML 43 R31.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders’ Equity (Tables)
12 Months Ended
Dec. 31, 2021
Equity [Abstract]  
Schedule of Stock Options Activity

The following table summarizes stock options activity during Fiscal 2021 and 2020 for the Amended 2010 Plan, the Amended 2010 Directors’ Plan, the 2018 Stock Plan and the Inducement Award (in thousands, except per share data).

 

   Number of Shares   Weighted Average Exercise Price  

Weighted Average

Remaining Contractual Life
(in years)

   Total Intrinsic Value 
Outstanding as of January 1, 2020   3,082    1.67    3.7    $1,085 
Granted   713    4.58    7.0    - 
Outstanding as of December 31, 2020   3,795   $2.21    3.4   $26,441 
Granted   1,825    7.29    6.2    - 
Forfeited   (505)   8.50    -    - 
Expired   (5)   1.39           
Outstanding as of December 31, 2021   5,110   $3.27    3.4   $20,820 
Options vested and exercisable   3,994   $2.51    2.6   $19,218 
Summary of Weighted Average Assumptions Used in Determining Fair Value of Options

The following table summarizes weighted average assumptions used in determining the fair value of the stock options at the date of grant during Fiscal 2021 and 2020:

 

   For the years ended 
   December 31, 
   2021   2020 
Exercise price  $7.29   $4.58 
Expected term (years)   4.0    4.2 
Expected stock price volatility   79%   52%
Risk-free rate of interest   0.8%   0%
Expected dividend yield (per share)   0%   0%
Schedule of Warrant Activity

The following table summarizes warrant activities during Fiscal 2021 and 2020 (in thousands, except per share data):

 

   Number of Shares  

Weighted Average

Exercise
Price

   Weighted Average
Remaining Contractual
Life
(in years)
 
Outstanding as of January 1, 2020   -   $-    - 
Warrants granted   450    3.22    3.0 
Outstanding as of December 31, 2020   450   $3.22    2.7 
Warrants granted   455    12.83    3.0 
Cashless exercise   (50)   5.00    - 
Outstanding as of December 31, 2021   855   $8.23    1.9 
Warrants vested and exercisable   855   $8.23    1.9 
Summary of Weighted Average Assumptions Used in Determining Fair Value of Warrants

The following table summarizes weighted average assumptions used in determining the fair value of the warrants at the date of grant during Fiscal 2021 and Fiscal 2020:

 

   For the years ended 
   December 31, 
   2021   2020 
Exercise price  $12.83   $3.22 
Expected term (years)   3.0    2.0 
Expected stock price volatility   81%   58%
Risk-free rate of interest   0.2%   0%
Expected dividend yield (per share)   0%   0%